Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GLENMARK PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    GLENMARK PHARMA
Mar-23
ADCOCK INGRAM
Jun-14
GLENMARK PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs487319-   
Low Rs349230-   
Sales per share (Unadj.) Rs460.494.9-  
Earnings per share (Unadj.) Rs13.4-23.9-  
Cash flow per share (Unadj.) Rs35.0-19.8-  
Dividends per share (Unadj.) Rs2.500-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs335.174.5-  
Shares outstanding (eoy) m282.17168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.92.9 31.4%   
Avg P/E ratio x31.3-11.5 -272.2%  
P/CF ratio (eoy) x11.9-13.9 -86.1%  
Price / Book Value ratio x1.23.7 33.8%  
Dividend payout %18.70-   
Avg Mkt Cap Rs m117,95346,340 254.5%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m27,8102,908 956.2%   
Avg. sales/employee Rs Th03,730.7-  
Avg. wages/employee Rs Th0677.5-  
Avg. net profit/employee Rs Th0-940.1-  
INCOME DATA
Net Sales Rs m129,90116,016 811.1%  
Other income Rs m3,168112 2,824.5%   
Total revenues Rs m133,06916,128 825.1%   
Gross profit Rs m15,125-2,775 -545.0%  
Depreciation Rs m6,113691 884.3%   
Interest Rs m3,496434 805.8%   
Profit before tax Rs m8,685-3,788 -229.2%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4,911237 2,074.4%   
Profit after tax Rs m3,774-4,036 -93.5%  
Gross profit margin %11.6-17.3 -67.2%  
Effective tax rate %56.5-6.2 -904.9%   
Net profit margin %2.9-25.2 -11.5%  
BALANCE SHEET DATA
Current assets Rs m98,73711,730 841.7%   
Current liabilities Rs m50,4556,600 764.5%   
Net working cap to sales %37.232.0 116.0%  
Current ratio x2.01.8 110.1%  
Inventory Days Days7111 6.0%  
Debtors Days Days115124 92.9%  
Net fixed assets Rs m76,9206,838 1,125.0%   
Share capital Rs m28274 379.5%   
"Free" reserves Rs m94,2810-   
Net worth Rs m94,56312,571 752.2%   
Long term debt Rs m38,5214,418 872.0%   
Total assets Rs m175,65823,747 739.7%  
Interest coverage x3.5-7.7 -45.1%   
Debt to equity ratio x0.40.4 115.9%  
Sales to assets ratio x0.70.7 109.6%   
Return on assets %4.1-15.2 -27.3%  
Return on equity %4.0-32.1 -12.4%  
Return on capital %9.2-19.8 -46.2%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m33,7510-   
CASH FLOW
From Operations Rs m6,2541,367 457.5%  
From Investments Rs m-5,285-420 1,259.0%  
From Financial Activity Rs m-7754,009 -19.3%  
Net Cashflow Rs m3254,957 6.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.4 Rs / ZAR

Compare GLENMARK PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare GLENMARK PHARMA With: CHEMO PHARMA  AAYUSH FOOD & HERBS   SUPRIYA LIFESCIENCE   BAFNA PHARMA  FABINO LIFE   



Today's Market

Sensex Today Ends 456 Points Lower | IT Stocks Drag | 5 Reasons Why Indian Share Market is Falling Sensex Today Ends 456 Points Lower | IT Stocks Drag | 5 Reasons Why Indian Share Market is Falling(Closing)

After opening the negative note, Indian share markets Slipped further as the session progressed and ended the day weak.